Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites

Journal of Hypertension

Volumn 21, Issue 1, 2003, Pages 87-95

  Zhu, Haidong ^a   Sagnella, Giuseppe A ^a   Dong, Yanbin ^a   Miller, Michelle A ^a   Onipinla, Abiodun ^a   Markandu, Nirmala D ^a   MacGregor, Graham A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Aldosterone synthase gene; Black Afro Caribbeans; Hypertension; Plasma renin activity

Indexed keywords

ALDOSTERONE SYNTHASE; GENE PRODUCT; MINERALOCORTICOID; PROTEIN K173R; SODIUM; UNCLASSIFIED DRUG;

ADULT; ALLELISM; ARTICLE; BLOOD PRESSURE REGULATION; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NEGRO; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE; SODIUM TRANSPORT; STEROID METABOLISM;

EID: 0037248330     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200301000-00018     Document Type: Article

References (31)

1. White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med 1994; 331:250-258.
2. Pascoe L, Curnow KM. Genetic recombination as a cause of inherited disorders of aldosterone and cortisol biosynthesis and a contributor to genetic variation in blood pressure. Steroids 1995; 60:22-27.
3. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000; 15:264-272.
4. Young M, Funder JW. Aldosterone and the heart. Trends Endocrinol Metab 2000; 11:224-226.
5. White PC, Slutsker L. Haplotype analysis of CYP11B2. Endocrinol Res 1995; 21;437-442.
6. Fardella CE, Rodriguez H, Montero J, Zhang G, Vignolo P, Rojas A, et al. Genetic variation in P450c11AS in Chilean patients with low renin hypertension. J Clin Endocrinol Metab 1996; 81:4347-4351.
7. Brand E, Chatelain N, Mulatero P, Fery I, Curnow K, Jeunemaitre X, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 1998; 32:198-204.
8. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 1999; 33:703-707.
9. Schunkert H, Hengstenberg C, Holmer SR, Broeckel U, Luchner A, Muscholl MW, et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation 1999; 99:2255-2260.
10. Patel S, Steeds R, Channer K, Samani NJ. Analysis of promoter region polymorphism in the aldosterone synthase gene (CYP11B2) as a risk factor for myocardial infarction. Am J Hypertens 2000; 13:134-139.
11. Kato N, Sugiyama T, Morita H, Kurihara H, Furukawa T, Isshiki T, et al. Comprehensive analysis of the renin-angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens 2000; 18:1025-1032.
12. Matsubara M, Kikuya M, Ohkubo T, Metoki H, Omori F, Fujiwara T, et al. Aldosterone synthase gene (CYP11B2) C-334T polymorphism, ambulatory blood pressure and nocturnal decline in blood pressure in the general Japanese population: the Ohasama Study. J Hypertens 2001; 19:2179-2184.
13. Tsujita Y, Iwai N, Katsuya T, Higaki J, Ogihara T, Tamaki S, et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res 2001; 24:105-109.
14. Rossi E, Regolisti G, Perazzoli F, Negro A, Davoli S, Nicoli D, et al. -344C/T polymorphism of CYP11B2 gene in Italian patients with idiopathic low renin hypertension. Am J Hypertens 2001; 14:934-941.
15. Komiya I, Yamada T, Takara M, Asawa T, Shimabukuro M, Nishimori T, et al. Lys(173)Arg and - 344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension 2000; 35:699-703.
16. Tamaki S, Iwai N, Tsujita Y, Kinoshita M. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 1999; 33:266-270.
17. Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart 1997; 78:555-563.
18. He FJ, Markandu ND, Sagnella GA, MacGregor GA. Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension 1998; 32:820-824.
19. Sagnella GA, Markandu ND, Shore AC, Forsling ML, MacGregor GA. Plasma atrial natriuretic peptide: its relationship to changes in sodium intake, plasma renin activity and aldosterone in man. Clin Sci 1987; 72:25-30.
20. Miller MA, Sagnella GA, MacGregor GA. Extraction method and nonextracted kit method compared for measuring plasma aldosterone. Clin Chem 1997; 43:1995-1997.
21. Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG, Cappuccio FP. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J Hypertens 1999; 17:657-664.
22. Dong YB, Baker EH, Sagnella GA, Carter ND, MacGregor GA. Use of single-strand conformation polymorphism analysis to screen for the T594M sodium channel mutation. Biochem Soc Trans 1998; 26:S393.
23. Falconer DS, Mackay FC. Introduction to quantitative genetics, 4th edn. London: Longman Group Ltd; 1996.
24. Matsubara M, Omori F, Fujita S, Metoki H, Kikuya M, Fujiwara T, et al. Haplotypes of aldosterone synthase (CYP11B2) gene in the general population of Japan: the Ohasama study. Clin Exp Hypertens 2001; 23:603-610.
25. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhager WH, Herrmann SM, et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 2001; 19:1349-1358.
26. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999; 34:423-429.
27. Hautanena A, Lankinen L, Kupari M, Janne OA, Adlercreutz H, Nikkila H, White PC. Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J Intern Med 1998; 244:11-18.
28. Davies E, Holloway CD, Ingram MC, Friel EC, Inglis GC, Swan L, et al. An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin Endocrinol 2001; 54:813-817.
29. de Simone G, Tommaselli AP, Rossi R, Valentino R, Lauria R, Scopacasa F, et al. Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension. Hypertension 1985; 7:204-210.
30. Inglis GC, Ingram MC, Holloway CD, Swan L, Birnie D, Hillis WS, et al. Familial pattern of corticosteroids and their metabolism in adult human subjects - the Scottish Adult Twin Study. J Clin Endocrinol Metab 1999; 84:4132-4137.
31. Schlaich MP, Klingbeil AU, Jacobi J, Delles C, Schneider MP, Schmidt BM, et al. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension. J Hypertens 2002; 20:117-124.